image credit: Unsplash

J&J asks FDA to clear booster dose of its coronavirus vaccine

October 5, 2021


For the past several months, one of the many questions hanging over the booster debate has ben what do with people who got J&J’s shot. The company’s application, and the FDA’s planned meeting, creates a timeline for answering that question.

Biden administration and public health officials drew on data from extensive real-world use of Pfizer’s and Moderna’s vaccine in the U.S., as well as from Israel’s rollout of Pfizer boosters, to inform their plans for additional messenger RNA doses.

Read More on Biopharma Dive